Dapagliflozin – September 2025

• Brand names:
  • Forxiga®
• Pharmaceutical Company:
  • ASTRAZENECA PTY LTD
• Condition/Indication: Chronic kidney disease (CKD)
• Meeting Date: September 2025
• Public Summary Document (PSD) September 2025 PBAC Meeting - (PDF 640KB)
• Public Summary Document (PSD) September 2025 PBAC Meeting - (Word 299KB)